Naveed Shams
Chairman presso InnFocus, Inc.
Profilo
Attualmente, Naveed K. Shams ricopre la posizione di Chief Scientific Officer, General Manager-R&D presso Santen Pharmaceutical Co., Ltd., Presidente presso InnFocus, Inc. (una filiale di Santen Pharmaceutical Co., Ltd.) e di Chief Scientific Officer presso ProQR Therapeutics NV. Nella sua carriera passata ha occupato la posizione di CMO, Senior Vice President-Research & Development presso OPKO Health, Inc, Senior Scientist & Glaucoma Group Leader-Discovery presso Storz Ophthalmics, Inc, Presidente, Chief Executive Officer & Director presso Santen, Inc, Senior Medical Director presso Genentech, Inc, Director-Clinical Science presso Novartis Ophthalmics, Inc e Member-Research Faculty presso Schepens Eye Research Institute. Naveed K. Shams si è laureato al Dow Medical College e ha conseguito il dottorato presso l'Università della Carolina del Sud.
Posizioni attive di Naveed Shams
Società | Posizione | Inizio |
---|---|---|
InnFocus, Inc.
InnFocus, Inc. BiotechnologyHealth Technology InnFocus, Inc. operates as an ophthalmology company that provides products for glaucoma surgery. Its product, InnFocus MicroShunt, is a glaucoma drainage implant consisting of a micro-tube twice the size of an eyelash. The company was founded by Leonard Pinchuk and John B. Martin Jr. in 2004 and is headquartered in Miami, FL. | Chairman | - |
Precedenti posizioni note di Naveed Shams
Società | Posizione | Fine |
---|---|---|
PROQR THERAPEUTICS N.V. | Chief Tech/Sci/R&D Officer | 01/01/2022 |
OPKO HEALTH, INC. | Chief Tech/Sci/R&D Officer | 10/06/2009 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/11/2007 |
Novartis Ophthalmics, Inc.
Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Chief Tech/Sci/R&D Officer | 01/09/2003 |
Storz Ophthalmics, Inc. | Corporate Officer/Principal | 01/03/1998 |
Formazione di Naveed Shams
University of South Carolina | Doctorate Degree |
Dow Medical College | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
OPKO HEALTH, INC. | Health Services |
PROQR THERAPEUTICS N.V. | Health Technology |
Aziende private | 6 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
The Schepens Eye Research Institute, Inc.
The Schepens Eye Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Schepens Eye Research Institute, Inc. operates as an eye research institute. It offers treatment for macular degeneration, diabetic retinopathy, glaucoma, other types of retinal and optic nerve degenerations and damage, dry eye and eye tissue transplants. The company was founded by Charles L. Schepens in 1950 and is headquartered in Boston, MA. | Commercial Services |
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a private company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Health Technology |
Storz Ophthalmics, Inc. | |
Novartis Ophthalmics, Inc.
Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Health Technology |
InnFocus, Inc.
InnFocus, Inc. BiotechnologyHealth Technology InnFocus, Inc. operates as an ophthalmology company that provides products for glaucoma surgery. Its product, InnFocus MicroShunt, is a glaucoma drainage implant consisting of a micro-tube twice the size of an eyelash. The company was founded by Leonard Pinchuk and John B. Martin Jr. in 2004 and is headquartered in Miami, FL. | Health Technology |
- Borsa valori
- Insiders
- Naveed Shams